Organon & Co | OGN - المديونيات المتداولة

سعر السهم
8.83
التغيير اليومي
1.92 27.79%
شهريا
37.97%
سنويا
-20.91%
Q2 التوقعات
8.59




المديونيات المتداولة تغيير تاريخ
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Merck USD 28.63B 2.59B 2025-09
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Ovoca Bio EUR 186K 2.26M 2025-06
Pharma Mar EUR 93.88M 4.94M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 664.96M 513.61M 2025-12